Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 172

1.

Preoperative chemoradiotherapy using cisplatin plus S-1 can induce downstaging in patients with locally advanced (stage III) non-small-cell lung cancer.

Kato M, Onishi H, Matsumoto K, Tsuruta N, Higuchi K, Motoshita J, Katano M.

Anticancer Res. 2012 Nov;32(11):5099-104.

PMID:
23155287
2.

Concurrent chemoradiotherapy using cisplatin plus S-1, an oral fluoropyrimidine, followed by surgery for selected patients with stage III non-small cell lung cancer: a single-center feasibility study.

Maruyama R, Hirai F, Ondo K, Kometani T, Hamatake M, Seto T, Sugio K, Ichinose Y.

Surg Today. 2011 Nov;41(11):1492-7. doi: 10.1007/s00595-011-4509-z. Epub 2011 Oct 4.

PMID:
21969151
3.

Comparison of vinorelbine plus cisplatin and S-1 plus cisplatin in concurrent chemoradiotherapeutic regimens for unresectable stage III non-small cell lung cancer.

Shukuya T, Takahashi T, Harada H, Akamatsu H, Sakaguchi C, Imai H, Ono A, Nakamura Y, Tsuya A, Kenmotsu H, Naito T, Murakami H, Endo M, Takahashi K, Yamamoto N.

Anticancer Res. 2012 Feb;32(2):675-80.

PMID:
22287762
4.

Preoperative concurrent chemoradiotherapy of S-1/cisplatin for stage III non-small cell lung cancer.

Yamaguchi M, Toyokawa G, Ohba T, Sasaki T, Kometani T, Hamatake M, Hirai F, Taguchi K, Yamanaka T, Seto T, Takenoyama M, Sugio K, Ichinose Y.

Ann Thorac Surg. 2013 Nov;96(5):1783-9. doi: 10.1016/j.athoracsur.2013.06.036. Epub 2013 Aug 30.

PMID:
23998404
5.

A multi-institutional phase II trial of consolidation S-1 after concurrent chemoradiotherapy with cisplatin and vinorelbine for locally advanced non-small cell lung cancer.

Kawaguchi T, Takada M, Ando M, Okishio K, Atagi S, Fujita Y, Tomizawa Y, Hayashihara K, Okano Y, Takahashi F, Saito R, Matsumura A, Tamura A.

Eur J Cancer. 2012 Mar;48(5):672-7. doi: 10.1016/j.ejca.2011.11.020. Epub 2011 Dec 13.

PMID:
22172569
6.

Two commonly used neoadjuvant chemoradiotherapy regimens for locally advanced stage III non-small cell lung carcinoma: long-term results and associations with pathologic response.

Machtay M, Lee JH, Stevenson JP, Shrager JB, Algazy KM, Treat J, Kaiser LR.

J Thorac Cardiovasc Surg. 2004 Jan;127(1):108-13.

7.

Short-course induction chemoradiotherapy with paclitaxel for stage III non-small-cell lung cancer.

Rice TW, Adelstein DJ, Ciezki JP, Becker ME, Rybicki LA, Farver CF, Larto MA, Blackstone EH.

Ann Thorac Surg. 1998 Dec;66(6):1909-14.

PMID:
9930467
8.

Phase II study of oral S-1 and cisplatin with concurrent radiotherapy for locally advanced non-small-cell lung cancer.

Kaira K, Tomizawa Y, Yoshino R, Yoshii A, Matsuura M, Iwasaki Y, Koga Y, Ono A, Nishioka M, Kamide Y, Hisada T, Ishizuka T, Shirai K, Ebara T, Saitoh J, Nakano T, Sunaga N.

Lung Cancer. 2013 Dec;82(3):449-54. doi: 10.1016/j.lungcan.2013.09.004. Epub 2013 Sep 19.

PMID:
24099666
9.

Chemoradiotherapy with or without AE-941 in stage III non-small cell lung cancer: a randomized phase III trial.

Lu C, Lee JJ, Komaki R, Herbst RS, Feng L, Evans WK, Choy H, Desjardins P, Esparaz BT, Truong MT, Saxman S, Kelaghan J, Bleyer A, Fisch MJ.

J Natl Cancer Inst. 2010 Jun 16;102(12):859-65. doi: 10.1093/jnci/djq179. Epub 2010 May 26.

10.

Potential impact on survival of improved tumor downstaging and resection rate by preoperative twice-daily radiation and concurrent chemotherapy in stage IIIA non-small-cell lung cancer.

Choi NC, Carey RW, Daly W, Mathisen D, Wain J, Wright C, Lynch T, Grossbard M, Grillo H.

J Clin Oncol. 1997 Feb;15(2):712-22.

PMID:
9053497
11.

Advantage of post-operative oral administration of UFT (tegafur and uracil) for completely resected p-stage I-IIIa non-small cell lung cancer (NSCLC).

Tanaka F, Miyahara R, Ohtake Y, Yanagihara K, Fukuse T, Hitomi S, Wada H.

Eur J Cardiothorac Surg. 1998 Sep;14(3):256-62; discussion 263-4.

PMID:
9761434
12.

A phase II trial of oral UFT plus cisplatin (CDDP) in patients with non-small cell lung cancer (NSCLC).

Saito J, Nakai Y, Saijo Y, Nukiwa T, Koinumaru S, Matsuura Y, Aso N, Yamane Y, Tsukamoto T, Sayama T, Nakabayashi T.

Lung Cancer. 2001 Feb-Mar;31(2-3):285-93.

PMID:
11165409
13.

Induction chemoradiotherapy and surgical resection for selected stage IIIB non-small-cell lung cancer.

Ichinose Y, Fukuyama Y, Asoh H, Ushijima C, Okamoto T, Ikeda J, Okamoto J, Sakai M.

Ann Thorac Surg. 2003 Dec;76(6):1810-4; discussion 1815.

PMID:
14667588
14.

Phase II study of uracil-tegafur plus cisplatin in patients with previously untreated advanced non-small cell lung cancer.

Takayama K, Kawasaki M, Ninomiya K, Motohiro A, Fujita M, Watanabe K, Kajiki A, Iwami F, Miyazaki N, Izumi M, Hara N, Nakanishi Y; Fukuoka Lung Cancer Study Group, Japan.

Respirology. 2008 Jan;13(1):103-7. doi: 10.1111/j.1440-1843.2007.01190.x.

PMID:
18197918
15.

A phase I study of combination S-1 plus cisplatin chemotherapy with concurrent thoracic radiation for locally advanced non-small cell lung cancer.

Chikamori K, Kishino D, Takigawa N, Hotta K, Nogami N, Kamei H, Kuyama S, Gemba K, Takemoto M, Kanazawa S, Ueoka H, Segawa Y, Takata S, Tabata M, Kiura K, Tanimoto M; Okayama Lung Cancer Study Group.

Lung Cancer. 2009 Jul;65(1):74-9. doi: 10.1016/j.lungcan.2008.10.019. Epub 2008 Dec 3.

PMID:
19056143
16.

Phase I study of oral S-1 plus Cisplatin with concurrent radiotherapy for locally advanced non-small-cell lung cancer.

Kaira K, Sunaga N, Yanagitani N, Kawata T, Utsugi M, Shimizu K, Ebara T, Kawamura H, Nonaka T, Ishikawa H, Sakurai H, Suga T, Hara K, Hisada T, Ishizuka T, Nakano T, Mori M.

Int J Radiat Oncol Biol Phys. 2009 Sep 1;75(1):109-14. doi: 10.1016/j.ijrobp.2008.06.1938. Epub 2008 Oct 15.

PMID:
18929446
17.

[UFT plus cisplatin with concurrent radiotherapy in unresectable stage III non-small cell lung cancer--its application to outpatient practice].

Yano T, Koga T, Nomiyama H, Hidaka H.

Gan To Kagaku Ryoho. 2003 Jul;30(7):959-62. Japanese.

PMID:
12894710
18.

Phase II trial of S-1 and cisplatin with concurrent radiotherapy for locally advanced non-small-cell lung cancer.

Ohyanagi F, Yamamoto N, Horiike A, Harada H, Kozuka T, Murakami H, Gomi K, Takahashi T, Morota M, Nishimura T, Endo M, Nakamura Y, Tsuya A, Horai T, Nishio M.

Br J Cancer. 2009 Jul 21;101(2):225-31. doi: 10.1038/sj.bjc.6605152.

19.
20.

[Effect of different chemotherapy regimens for concurrent chemoradiotherapy on locally advanced non-small cell lung cancer].

Ren H, Wang LH, Wang XZ, Lü JM, Ji W, Zhou ZM, Ou GF, Yin WB.

Zhonghua Zhong Liu Za Zhi. 2009 Feb;31(2):143-7. Chinese.

PMID:
19538894
Items per page

Supplemental Content

Write to the Help Desk